NCT05774509View on ClinicalTrials.gov

Treatment of Non-ischemic Cardiomyopathies by Intravenous Extracellular Vesicles of Cardiovascular Progenitor Cells

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

August 15, 2025

Study Completion Date

July 15, 2026

Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
BIOLOGICAL

Extracellular vesicle-enriched secretome of cardiovascular progenitor cells differentiated from induced pluripotent stem cells

Repeated (X3) intravenous infusions of the extracellular vesicle-enriched secretome of cardiovascular progenitor cells (differentiated from human induced pluripotent stem cells)

Trial Locations (1)

75015

RECRUITING

Hôpital européen Georges Pompidou, Paris

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER